Global Human Prothrombin Complex Market Size, Manufacturers, Opportunities and Forecast to 2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
According to APO Research, The global Human Prothrombin Complex market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Global Human Prothrombin Complex key players include Octapharma, Shire, CSL, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 45%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, 500 IU/Vial is the largest segment, with a share over 50%. And in terms of application, the largest application is Hemophilia B, followed by Vitamin K Deficiency, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Human Prothrombin Complex, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Prothrombin Complex.
The Human Prothrombin Complex market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Prothrombin Complex market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Prothrombin Complex market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Prothrombin Complex and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Prothrombin Complex.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Prothrombin Complex manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Human Prothrombin Complex in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
According to APO Research, The global Human Prothrombin Complex market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Global Human Prothrombin Complex key players include Octapharma, Shire, CSL, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 45%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, 500 IU/Vial is the largest segment, with a share over 50%. And in terms of application, the largest application is Hemophilia B, followed by Vitamin K Deficiency, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Human Prothrombin Complex, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Prothrombin Complex.
The Human Prothrombin Complex market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Prothrombin Complex market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Takeda
- CSL
- Grifols
- Octapharma
- Hualan Biological
- Meheco Xinxing Pharma
- 500 IU/Vial
- 600 IU/Vial
- 1000 IU/Vial
- Others
- Hemophilia B
- Vitamin K Deficiency
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Prothrombin Complex market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Prothrombin Complex and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Prothrombin Complex.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Prothrombin Complex manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Human Prothrombin Complex in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Human Prothrombin Complex Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Human Prothrombin Complex Sales Estimates and Forecasts (2019-2030)
1.3 Human Prothrombin Complex Market by Type
1.3.1 500 IU/Vial
1.3.2 600 IU/Vial
1.3.3 1000 IU/Vial
1.3.4 Others
1.4 Global Human Prothrombin Complex Market Size by Type
1.4.1 Global Human Prothrombin Complex Market Size Overview by Type (2019-2030)
1.4.2 Global Human Prothrombin Complex Historic Market Size Review by Type (2019-2024)
1.4.3 Global Human Prothrombin Complex Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Human Prothrombin Complex Sales Breakdown by Type (2019-2024)
1.5.2 Europe Human Prothrombin Complex Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Human Prothrombin Complex Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Human Prothrombin Complex Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Human Prothrombin Complex Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 Human Prothrombin Complex Industry Trends
2.2 Human Prothrombin Complex Industry Drivers
2.3 Human Prothrombin Complex Industry Opportunities and Challenges
2.4 Human Prothrombin Complex Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Human Prothrombin Complex Revenue (2019-2024)
3.2 Global Top Players by Human Prothrombin Complex Sales (2019-2024)
3.3 Global Top Players by Human Prothrombin Complex Price (2019-2024)
3.4 Global Human Prothrombin Complex Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Human Prothrombin Complex Key Company Manufacturing Sites & Headquarters
3.6 Global Human Prothrombin Complex Company, Product Type & Application
3.7 Global Human Prothrombin Complex Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Human Prothrombin Complex Market CR5 and HHI
3.8.2 Global Top 5 and 10 Human Prothrombin Complex Players Market Share by Revenue in 2023
3.8.3 2023 Human Prothrombin Complex Tier 1, Tier 2, and Tier
4 HUMAN PROTHROMBIN COMPLEX REGIONAL STATUS AND OUTLOOK
4.1 Global Human Prothrombin Complex Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Human Prothrombin Complex Historic Market Size by Region
4.2.1 Global Human Prothrombin Complex Sales in Volume by Region (2019-2024)
4.2.2 Global Human Prothrombin Complex Sales in Value by Region (2019-2024)
4.2.3 Global Human Prothrombin Complex Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Human Prothrombin Complex Forecasted Market Size by Region
4.3.1 Global Human Prothrombin Complex Sales in Volume by Region (2025-2030)
4.3.2 Global Human Prothrombin Complex Sales in Value by Region (2025-2030)
4.3.3 Global Human Prothrombin Complex Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 HUMAN PROTHROMBIN COMPLEX BY APPLICATION
5.1 Human Prothrombin Complex Market by Application
5.1.1 Hemophilia B
5.1.2 Vitamin K Deficiency
5.1.3 Others
5.2 Global Human Prothrombin Complex Market Size by Application
5.2.1 Global Human Prothrombin Complex Market Size Overview by Application (2019-2030)
5.2.2 Global Human Prothrombin Complex Historic Market Size Review by Application (2019-2024)
5.2.3 Global Human Prothrombin Complex Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Human Prothrombin Complex Sales Breakdown by Application (2019-2024)
5.3.2 Europe Human Prothrombin Complex Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Human Prothrombin Complex Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Human Prothrombin Complex Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Human Prothrombin Complex Sales Breakdown by Application (2019-2024)
6 COMPANY PROFILES
6.1 Takeda
6.1.1 Takeda Comapny Information
6.1.2 Takeda Business Overview
6.1.3 Takeda Human Prothrombin Complex Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Takeda Human Prothrombin Complex Product Portfolio
6.1.5 Takeda Recent Developments
6.2 CSL
6.2.1 CSL Comapny Information
6.2.2 CSL Business Overview
6.2.3 CSL Human Prothrombin Complex Sales, Revenue and Gross Margin (2019-2024)
6.2.4 CSL Human Prothrombin Complex Product Portfolio
6.2.5 CSL Recent Developments
6.3 Grifols
6.3.1 Grifols Comapny Information
6.3.2 Grifols Business Overview
6.3.3 Grifols Human Prothrombin Complex Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Grifols Human Prothrombin Complex Product Portfolio
6.3.5 Grifols Recent Developments
6.4 Octapharma
6.4.1 Octapharma Comapny Information
6.4.2 Octapharma Business Overview
6.4.3 Octapharma Human Prothrombin Complex Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Octapharma Human Prothrombin Complex Product Portfolio
6.4.5 Octapharma Recent Developments
6.5 Hualan Biological
6.5.1 Hualan Biological Comapny Information
6.5.2 Hualan Biological Business Overview
6.5.3 Hualan Biological Human Prothrombin Complex Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Hualan Biological Human Prothrombin Complex Product Portfolio
6.5.5 Hualan Biological Recent Developments
6.6 Meheco Xinxing Pharma
6.6.1 Meheco Xinxing Pharma Comapny Information
6.6.2 Meheco Xinxing Pharma Business Overview
6.6.3 Meheco Xinxing Pharma Human Prothrombin Complex Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Meheco Xinxing Pharma Human Prothrombin Complex Product Portfolio
6.6.5 Meheco Xinxing Pharma Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Human Prothrombin Complex Sales by Country
7.1.1 North America Human Prothrombin Complex Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Human Prothrombin Complex Sales by Country (2019-2024)
7.1.3 North America Human Prothrombin Complex Sales Forecast by Country (2025-2030)
7.2 North America Human Prothrombin Complex Market Size by Country
7.2.1 North America Human Prothrombin Complex Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Human Prothrombin Complex Market Size by Country (2019-2024)
7.2.3 North America Human Prothrombin Complex Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe Human Prothrombin Complex Sales by Country
8.1.1 Europe Human Prothrombin Complex Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Human Prothrombin Complex Sales by Country (2019-2024)
8.1.3 Europe Human Prothrombin Complex Sales Forecast by Country (2025-2030)
8.2 Europe Human Prothrombin Complex Market Size by Country
8.2.1 Europe Human Prothrombin Complex Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Human Prothrombin Complex Market Size by Country (2019-2024)
8.2.3 Europe Human Prothrombin Complex Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Human Prothrombin Complex Sales by Country
9.1.1 Asia-Pacific Human Prothrombin Complex Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Human Prothrombin Complex Sales by Country (2019-2024)
9.1.3 Asia-Pacific Human Prothrombin Complex Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Human Prothrombin Complex Market Size by Country
9.2.1 Asia-Pacific Human Prothrombin Complex Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Human Prothrombin Complex Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Human Prothrombin Complex Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America Human Prothrombin Complex Sales by Country
10.1.1 Latin America Human Prothrombin Complex Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Human Prothrombin Complex Sales by Country (2019-2024)
10.1.3 Latin America Human Prothrombin Complex Sales Forecast by Country (2025-2030)
10.2 Latin America Human Prothrombin Complex Market Size by Country
10.2.1 Latin America Human Prothrombin Complex Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Human Prothrombin Complex Market Size by Country (2019-2024)
10.2.3 Latin America Human Prothrombin Complex Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Human Prothrombin Complex Sales by Country
11.1.1 Middle East and Africa Human Prothrombin Complex Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Human Prothrombin Complex Sales by Country (2019-2024)
11.1.3 Middle East and Africa Human Prothrombin Complex Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Human Prothrombin Complex Market Size by Country
11.2.1 Middle East and Africa Human Prothrombin Complex Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Human Prothrombin Complex Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Human Prothrombin Complex Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Human Prothrombin Complex Value Chain Analysis
12.1.1 Human Prothrombin Complex Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Human Prothrombin Complex Production Mode & Process
12.2 Human Prothrombin Complex Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Human Prothrombin Complex Distributors
12.2.3 Human Prothrombin Complex Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Human Prothrombin Complex Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Human Prothrombin Complex Sales Estimates and Forecasts (2019-2030)
1.3 Human Prothrombin Complex Market by Type
1.3.1 500 IU/Vial
1.3.2 600 IU/Vial
1.3.3 1000 IU/Vial
1.3.4 Others
1.4 Global Human Prothrombin Complex Market Size by Type
1.4.1 Global Human Prothrombin Complex Market Size Overview by Type (2019-2030)
1.4.2 Global Human Prothrombin Complex Historic Market Size Review by Type (2019-2024)
1.4.3 Global Human Prothrombin Complex Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Human Prothrombin Complex Sales Breakdown by Type (2019-2024)
1.5.2 Europe Human Prothrombin Complex Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Human Prothrombin Complex Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Human Prothrombin Complex Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Human Prothrombin Complex Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 Human Prothrombin Complex Industry Trends
2.2 Human Prothrombin Complex Industry Drivers
2.3 Human Prothrombin Complex Industry Opportunities and Challenges
2.4 Human Prothrombin Complex Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Human Prothrombin Complex Revenue (2019-2024)
3.2 Global Top Players by Human Prothrombin Complex Sales (2019-2024)
3.3 Global Top Players by Human Prothrombin Complex Price (2019-2024)
3.4 Global Human Prothrombin Complex Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Human Prothrombin Complex Key Company Manufacturing Sites & Headquarters
3.6 Global Human Prothrombin Complex Company, Product Type & Application
3.7 Global Human Prothrombin Complex Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Human Prothrombin Complex Market CR5 and HHI
3.8.2 Global Top 5 and 10 Human Prothrombin Complex Players Market Share by Revenue in 2023
3.8.3 2023 Human Prothrombin Complex Tier 1, Tier 2, and Tier
4 HUMAN PROTHROMBIN COMPLEX REGIONAL STATUS AND OUTLOOK
4.1 Global Human Prothrombin Complex Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Human Prothrombin Complex Historic Market Size by Region
4.2.1 Global Human Prothrombin Complex Sales in Volume by Region (2019-2024)
4.2.2 Global Human Prothrombin Complex Sales in Value by Region (2019-2024)
4.2.3 Global Human Prothrombin Complex Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Human Prothrombin Complex Forecasted Market Size by Region
4.3.1 Global Human Prothrombin Complex Sales in Volume by Region (2025-2030)
4.3.2 Global Human Prothrombin Complex Sales in Value by Region (2025-2030)
4.3.3 Global Human Prothrombin Complex Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 HUMAN PROTHROMBIN COMPLEX BY APPLICATION
5.1 Human Prothrombin Complex Market by Application
5.1.1 Hemophilia B
5.1.2 Vitamin K Deficiency
5.1.3 Others
5.2 Global Human Prothrombin Complex Market Size by Application
5.2.1 Global Human Prothrombin Complex Market Size Overview by Application (2019-2030)
5.2.2 Global Human Prothrombin Complex Historic Market Size Review by Application (2019-2024)
5.2.3 Global Human Prothrombin Complex Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Human Prothrombin Complex Sales Breakdown by Application (2019-2024)
5.3.2 Europe Human Prothrombin Complex Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Human Prothrombin Complex Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Human Prothrombin Complex Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Human Prothrombin Complex Sales Breakdown by Application (2019-2024)
6 COMPANY PROFILES
6.1 Takeda
6.1.1 Takeda Comapny Information
6.1.2 Takeda Business Overview
6.1.3 Takeda Human Prothrombin Complex Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Takeda Human Prothrombin Complex Product Portfolio
6.1.5 Takeda Recent Developments
6.2 CSL
6.2.1 CSL Comapny Information
6.2.2 CSL Business Overview
6.2.3 CSL Human Prothrombin Complex Sales, Revenue and Gross Margin (2019-2024)
6.2.4 CSL Human Prothrombin Complex Product Portfolio
6.2.5 CSL Recent Developments
6.3 Grifols
6.3.1 Grifols Comapny Information
6.3.2 Grifols Business Overview
6.3.3 Grifols Human Prothrombin Complex Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Grifols Human Prothrombin Complex Product Portfolio
6.3.5 Grifols Recent Developments
6.4 Octapharma
6.4.1 Octapharma Comapny Information
6.4.2 Octapharma Business Overview
6.4.3 Octapharma Human Prothrombin Complex Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Octapharma Human Prothrombin Complex Product Portfolio
6.4.5 Octapharma Recent Developments
6.5 Hualan Biological
6.5.1 Hualan Biological Comapny Information
6.5.2 Hualan Biological Business Overview
6.5.3 Hualan Biological Human Prothrombin Complex Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Hualan Biological Human Prothrombin Complex Product Portfolio
6.5.5 Hualan Biological Recent Developments
6.6 Meheco Xinxing Pharma
6.6.1 Meheco Xinxing Pharma Comapny Information
6.6.2 Meheco Xinxing Pharma Business Overview
6.6.3 Meheco Xinxing Pharma Human Prothrombin Complex Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Meheco Xinxing Pharma Human Prothrombin Complex Product Portfolio
6.6.5 Meheco Xinxing Pharma Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Human Prothrombin Complex Sales by Country
7.1.1 North America Human Prothrombin Complex Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Human Prothrombin Complex Sales by Country (2019-2024)
7.1.3 North America Human Prothrombin Complex Sales Forecast by Country (2025-2030)
7.2 North America Human Prothrombin Complex Market Size by Country
7.2.1 North America Human Prothrombin Complex Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Human Prothrombin Complex Market Size by Country (2019-2024)
7.2.3 North America Human Prothrombin Complex Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe Human Prothrombin Complex Sales by Country
8.1.1 Europe Human Prothrombin Complex Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Human Prothrombin Complex Sales by Country (2019-2024)
8.1.3 Europe Human Prothrombin Complex Sales Forecast by Country (2025-2030)
8.2 Europe Human Prothrombin Complex Market Size by Country
8.2.1 Europe Human Prothrombin Complex Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Human Prothrombin Complex Market Size by Country (2019-2024)
8.2.3 Europe Human Prothrombin Complex Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Human Prothrombin Complex Sales by Country
9.1.1 Asia-Pacific Human Prothrombin Complex Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Human Prothrombin Complex Sales by Country (2019-2024)
9.1.3 Asia-Pacific Human Prothrombin Complex Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Human Prothrombin Complex Market Size by Country
9.2.1 Asia-Pacific Human Prothrombin Complex Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Human Prothrombin Complex Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Human Prothrombin Complex Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America Human Prothrombin Complex Sales by Country
10.1.1 Latin America Human Prothrombin Complex Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Human Prothrombin Complex Sales by Country (2019-2024)
10.1.3 Latin America Human Prothrombin Complex Sales Forecast by Country (2025-2030)
10.2 Latin America Human Prothrombin Complex Market Size by Country
10.2.1 Latin America Human Prothrombin Complex Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Human Prothrombin Complex Market Size by Country (2019-2024)
10.2.3 Latin America Human Prothrombin Complex Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Human Prothrombin Complex Sales by Country
11.1.1 Middle East and Africa Human Prothrombin Complex Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Human Prothrombin Complex Sales by Country (2019-2024)
11.1.3 Middle East and Africa Human Prothrombin Complex Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Human Prothrombin Complex Market Size by Country
11.2.1 Middle East and Africa Human Prothrombin Complex Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Human Prothrombin Complex Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Human Prothrombin Complex Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Human Prothrombin Complex Value Chain Analysis
12.1.1 Human Prothrombin Complex Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Human Prothrombin Complex Production Mode & Process
12.2 Human Prothrombin Complex Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Human Prothrombin Complex Distributors
12.2.3 Human Prothrombin Complex Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
